NCT04864119View on ClinicalTrials.gov

DEFINing the PrEvalence and Characteristics of Coronary Artery Disease Among Patients With TYPE 2 Myocardial Infarction Using CT-FFR

CompletedOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

April 11, 2021

Primary Completion Date

February 3, 2023

Study Completion Date

March 11, 2024

Conditions

Type 2 Myocardial Infarction

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

HeartFlow, Inc.

All Listed Sponsors

collaborator

HeartFlow, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER